QC release testing of biopharmaceutical products

 
Home /

QC release testing of biopharmaceutical products

The emergence of increasing numbers of biotechnology-derived pharmaceuticals has led to the development of a set of specialized tests and assays to determine the identity, quality, purity and potency of this class of drug

Almac has a long-standing status as a center of excellence for pharmaceutical release testing to the highest level of cGMP compliance. This enables us to develop and validate analytical methods, work from pharmacoepial methods and design & execute validation protocols for client methods were appropriate.

Our biopharmaceutical release testing services:

  • General pharmacopoeial tests including appearance, osmolarity, pH, etc.
  • HPLC assay for purity assessment and related proteins
  • Isoelectric Focusing (IEF) for charge heterogeneity analysis
  • Peptide mapping using chromatographic, gel electrophoresis and LC-MS methods
  • Size Exclusion Chromatography (SEC) for aggregate analysis and molecular size
  • Gel electrophoresis (SDS-PAGE; native PAGE; Gel IEF; 2-D PAGE)
  • Protein concentration (Folin-Lowry; Bradford; BCA; UV determination; Kjeldahl method)
  • Amino acid analysis
  • Process-related impurity screening
  • Bacterial endotoxins (gel clot method)
  • Host cell protein (HCPs) determination – multiplex ELISA
  • cGMP Cell-based Bioassays (through our cGMP-accredited partners)
  • PK/PD analysis using a validated ELISA for the test biologic
  • A parallel study using an ELISA for detection of antibodies raised in the patient against the drug (anti-drug antibodies, or ADA’s)

Additional methods may be available upon client request.

Contact Us

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies